Composition 150 mg
Observations for this pharmaceutical form can be found on the lists:WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
For use only in patients with HIV receiving protease inhibitors.
2.3. Antituberculosis med.
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
6.2.10 Antituberculosos y antileprosos
- No observations